Megaloblastic anemia is a type of anemia characterized by the presence of large, immature red blood cells called megaloblasts. The classic clinical symptoms include fatigue, weakness, pallor, palpitations, and dizziness, reflecting the underlying anemia. Neurological signs, such as paresthesias, ataxia, and cognitive impairment, may also be present in cases of vitamin B12 deficiency. Physical examination may reveal signs of digestive involvement, like glossitis and intestinal motility disorders. The key laboratory findings in the diagnosis of megaloblastic anemia include macrocytic, normochromic anemia, the presence of megaloblasts and macrocytes on the blood smear, and decreased levels of vitamin B12 and/or folate. Elevated homocysteine and methylmalonic acid levels can also be observed in vitamin B12 deficiency. In cases of suspected malabsorption, further testing, such as the Schilling test, endoscopy, and intestinal biopsy, may be necessary to identify the underlying cause. A comprehensive clinical assessment and the interpretation of laboratory results are essential for the accurate diagnosis and appropriate management of megaloblastic anemia. Understanding the various clinical and laboratory aspects of this condition is crucial for healthcare professionals to ensure timely and effective diagnosis and treatment.